HAVN Life Sciences Statistics
Total Valuation
HAVLF has a market cap or net worth of 621,259. The enterprise value is 630,114.
| Market Cap | 621,259 |
| Enterprise Value | 630,114 |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 28.65M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +59.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.05 |
| EV / Sales | 1.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.68 |
| Quick Ratio | 0.60 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -235.74 |
Financial Efficiency
Return on equity (ROE) is -234.52% and return on invested capital (ROIC) is -32.50%.
| Return on Equity (ROE) | -234.52% |
| Return on Assets (ROA) | -30.27% |
| Return on Invested Capital (ROIC) | -32.50% |
| Return on Capital Employed (ROCE) | -416.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.00% in the last 52 weeks. The beta is -0.56, so HAVLF's price volatility has been lower than the market average.
| Beta (5Y) | -0.56 |
| 52-Week Price Change | -95.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 44.03 |
| Average Volume (20 Days) | 3,397 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HAVLF had revenue of 440,114 and -11.78 million in losses. Loss per share was -1.65.
| Revenue | 440,114 |
| Gross Profit | 156,416 |
| Operating Income | -2.70M |
| Pretax Income | -11.78M |
| Net Income | -11.78M |
| EBITDA | -2.63M |
| EBIT | -2.70M |
| Loss Per Share | -1.65 |
Balance Sheet
The company has 10,487 in cash and 19,670 in debt, giving a net cash position of -9,184.
| Cash & Cash Equivalents | 10,487 |
| Total Debt | 19,670 |
| Net Cash | -9,184 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 628,195 |
| Book Value Per Share | 0.04 |
| Working Capital | 646,709 |
Cash Flow
| Operating Cash Flow | -1.96M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 35.54% |
| Operating Margin | -612.60% |
| Pretax Margin | -2,676.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HAVLF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.53% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,896.16% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 3, 2022. It was a reverse split with a ratio of 0.0333333333.
| Last Split Date | Aug 3, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0333333333 |
Scores
HAVLF has an Altman Z-Score of -58.17 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -58.17 |
| Piotroski F-Score | 1 |